Total recalls 17 since 2015
Last 12 months 0 reported
Class I 1 6% of total
Ongoing 0 latest 2 Sep 2020
Recalls per month, last 24 months click a bar for that month Severity split
1 6%5 29%11 65%
Why par pharmaceutical is recalled
All par pharmaceutical recalls, newest first 17 total Reported Class Recall Company Reason Where 2 Sep 2020 Drug CLASS II BusPIRone Hydrochloride Tablets, USP 7.5 mg recalled Par Pharmaceutical Potency & Assay Nationwide 8 Apr 2020 Drug CLASS II Glycopyrrolate Tablets, USP 1 mg recalled by Par Pharmaceutical Par Pharmaceutical Potency & Assay NY 25 Mar 2020 Drug CLASS III PrediniSONE Tablets, USP 5 mg recalled by Par Pharmaceutical Prednisone Par Pharmaceutical Other Nationwide 19 Feb 2020 Drug CLASS III Frovatriptan Succinate Tablets, 2.5mg recalled by Par Pharmaceutical Par Pharmaceutical Labeling Errors Nationwide 15 May 2019 Drug CLASS I Mycophenolate Mofetil for Injection, USP 500 mg Dose Vials recalled Mycophenolate Mofetil Par Pharmaceutical Particulate Matter Nationwide 19 Sep 2018 Drug CLASS III Pramipexole dihydrochloride extended release tablets, 0.75 mg recalled Par Pharmaceutical Potency & Assay Nationwide 7 Dec 2016 Drug CLASS II Travoprost Ophthalmic Solution USP, 0.004%, a) and b) recalled Par Pharmaceutical Sterility Nationwide 9 Nov 2016 Drug CLASS III Gildess 1/20 (norethindrone acetate, 1 mg recalled by Par Pharmaceutical Par Pharmaceutical Potency & Assay Nationwide 9 Nov 2016 Drug CLASS III Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg recalled Par Pharmaceutical Potency & Assay Nationwide 9 Nov 2016 Drug CLASS III Gildess 1.5/30 (norethindrone acetate, 1.5 mg recalled Par Pharmaceutical Potency & Assay Nationwide 9 Nov 2016 Drug CLASS III Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg recalled Par Pharmaceutical Potency & Assay Nationwide 9 Nov 2016 Drug CLASS III Gildess FE 1/20 (norethindrone acetate, 1 mg recalled Par Pharmaceutical Potency & Assay Nationwide 22 Jun 2016 Drug CLASS III Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg recalled Par Pharmaceutical Potency & Assay Nationwide 25 Nov 2015 Drug CLASS III Meclizine Hydrochloride Tablets recalled by Par Pharmaceutical Par Pharmaceutical Potency & Assay Nationwide 25 Nov 2015 Drug CLASS III Meclizine Hydrochloride Tablets recalled by Par Pharmaceutical Par Pharmaceutical Potency & Assay Nationwide 4 Mar 2015 Drug CLASS II Mafenide Acetate, USP, For 5% Topical Solution, Sterile recalled Par Pharmaceutical Other Nationwide 14 Jan 2015 Drug CLASS II HydrALAZINE Hydrochloride Tablets, USP 25 mg recalled Par Pharmaceutical Particulate Matter Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.